At the Institute for Cellular and Molecular Medicine, we engage in transdisciplinary, translational research and innovation pertaining to:

• Communicable and non-communicable disease burden in South Africa
• Genetics of disease
• Cellular and molecular therapy products
• Generation of commercialisable intellectual property (bio-entrepreneurship)
• Legislation and regulation of advanced therapies

The ICMM ultimately aims to find sustainable laboratory bench to bedside solutions for the overwhelming burden of communicable and non-communicable diseases in South Africa. We strive for full-circle therapies, beginning with fundamental laboratory research questions and ending with patient benefit, using a market-driven approach.